Hematologic malignancies, encompassing disorders such as leukemia, lymphoma, and myeloma, along with various solid tumors, pose formidable challenges to healthcare systems and patients alike. However, recent advancements in the field of hemato oncology testing have ushered in a new era of precision medicine, where treatment decisions are guided by the unique genetic and molecular characteristics […]
